INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 105 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $43,605 | -74.8% | 13,500 | -89.6% | 0.00% | -100.0% |
| Q2 2016 | $173,000 | -74.7% | 130,000 | 0.0% | 0.00% | -75.0% |
| Q1 2016 | $685,000 | +22733.3% | 130,000 | +48407.5% | 0.00% | – |
| Q2 2015 | $3,000 | -98.7% | 268 | -98.1% | 0.00% | -100.0% |
| Q4 2014 | $233,000 | -80.4% | 13,804 | -84.0% | 0.00% | -87.5% |
| Q4 2013 | $1,191,000 | -58.5% | 86,295 | -47.5% | 0.01% | -71.4% |
| Q3 2013 | $2,867,000 | -38.1% | 164,521 | -42.5% | 0.03% | -44.0% |
| Q2 2013 | $4,629,000 | – | 285,885 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
| Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
| BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
| Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
| HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
| Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
| SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
| Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |